Flaviviruses and Flavivirus Vaccines
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".
Deadline for manuscript submissions: closed (30 April 2022) | Viewed by 29741
Special Issue Editor
Special Issue Information
Dear Colleagues,
The Flaviviruses represent a family of positive, single-stranded, enveloped RNA viruses which can be transmitted by arthropods such as mosquitoes and ticks. It includes the Yellow Fever virus, Dengue virus, Japanese encephalitis, West Nile viruses, and Zika virus. They can cause a spectrum of potentially severe diseases including hepatitis, vascular shock syndrome, encephalitis, acute flaccid paralysis, congenital abnormalities and fetal death. Flaviviruses are now globally distributed and infect up to 400 million people each year and mainly spreading in the tropical region which covered the majority of the poverty countries such as south and southeast Asia and Africa. During the last 70 years, multiple epidemics have occurred, including epidemics of dengue virus and West Nile virus, and the most recent explosive epidemic of Zika virus in the Americas. To counter the Flavivirus infection, vaccine is the ultimately approach. Currently, commercially available licensed vaccines exist for five flaviviruses (YFV, DENV, JEV, KFDV and TBEV), and several others have been evaluated in preclinical and clinical studies. This Special Issue is focus on the flavivirus and flavivirus vaccine to understanding the pathogenesis and vaccine development for flavivirus
Dr. Chao Shan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- flavivirus and animal model
- vaccine development
- vector control
- antibody-dependent enhancement
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.